Skip to main content

Trump Administration Should Reject Foreign Prescription Drug Price Controls

In responding to the coronavirus pandemic, President Trump has rightly focused on the tremendous innovative capacity of American businesses -- first by waiving regulations that impose unnecessary burdens, next by providing incentives to get tough jobs such as vaccine development done as quickly as possible.

Read the full story here